Description

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Introduction

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine is an intermediate of imatinib. Imatinib is a first-generation tyrosine kinase inhibitor, a drug for the treatment of chronic myeloid leukemia. It only kills BCR-ABL contained in myeloid cells, preventing cell proliferation and tumor formation, but has no effect on normal cells. It also inhibits PDGF-mediated tumors, including gliomas and prostate cancer.

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Specification

Melting Point	133-135℃
Boiling Point	537.3±60.0℃
Form	Yellow solid
Density	1.266±0.06 g/cm3
Packaging	1g, 5g, 10g, 25g, 100g, 500g, etc.

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Applications

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine is an intermediate of imatinib.

Reviews

5 Stars

4 Stars

3 Stars

2 Stars

1 Stars

Write a review

Get a Quote

Send us an inquiry now to find out more information and the latest prices, thanks!

Product Name

Quantity

Name

Phone

Company

Application

Country

United States

United States
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Disputed Territory
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Federated States of Micronesia
Fiji
Finland
France
French Guyana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and Mcdonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Iraq-Saudi Arabia Neutral Zone
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands Antilles
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Helena and Dependencies
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and South Sandwich Islands
South Korea
Spain
Spratly Islands
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
US Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe

Comments

I would like to join the mailing list to receive updates from Stanford Chemicals.

Check Code

Type	Active Pharmaceutical ingredient
Synonym	2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine; N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
CAS No.	152460-10-1
Chemical Formula	C₁₆H₁₅N₅
Packaging	1g, 5g, 10g, 25g, 100g, 500g, etc.
Form	Yellow solid
Assay	≥98%
Related Products	Gefitinib; 4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride; Dasatinib Monohydrate.

Medical Grade Sodium Hyaluronate

Cosmetic Grade Sodium Hyaluronate

Food Grade Hyaluronic Acid

Inection Grade Sodium Hyaluronate

Micro Hyaluronic Acid

Hyaluronic Acid Elastomer

Remdesivir

3-Amino-2-chloro-4-methylpyridine

4-Bromopyrazole

Folic Acid

Chondroitin Sulfate

Vitamin B3

Apigenin

Fisetin

Artemisinin

Dihydromyricetin

Salicin

CoenzymeQ10

SKIP TO

040-000-546 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine

About This Item

Quantity

Technical Service

Description

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Introduction

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Specification

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Applications

Reviews

Get a Quote

SKIP TO

040-000-546 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine

About This Item

Quantity

Technical Service

Description

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Introduction

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Specification

4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine Applications

Reviews

Related Products

Write a Review

Get a Quote